ViGenCell Inc. (KOSDAQ:308080)
South Korea
· Delayed Price · Currency is KRW 10,200
+1,200 (13.33%)
At close: Dec 5, 2025
ViGenCell Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 278.95 | 278.95 | - | - | - |
| Cost of Revenue | 274.65 | 281.11 | 0.84 | 3.45 | 2.9 |
| Gross Profit | 4.3 | -2.17 | -0.84 | -3.45 | -2.9 |
| Selling, General & Admin | 2,559 | 2,827 | 3,449 | 4,774 | 5,303 |
| Research & Development | 10,255 | 11,576 | 15,452 | 12,285 | 6,819 |
| Amortization of Goodwill & Intangibles | 74.64 | 77.11 | 67.98 | 14.39 | 12.62 |
| Other Operating Expenses | 76.57 | 80.69 | 91.64 | 115.69 | 73.82 |
| Operating Expenses | 13,566 | 15,328 | 20,084 | 18,210 | 13,133 |
| Operating Income | -13,562 | -15,330 | -20,084 | -18,214 | -13,136 |
| Interest Expense | -362.1 | -363.57 | -399.27 | -289.2 | -352.68 |
| Interest & Investment Income | 535.91 | 795.02 | 2,248 | 1,219 | 99.41 |
| Currency Exchange Gain (Loss) | -4.8 | -6.16 | 0.79 | -8.35 | 1.29 |
| Other Non Operating Income (Expenses) | -23.3 | -19.03 | 0.32 | -1.7 | 2,105 |
| EBT Excluding Unusual Items | -13,416 | -14,924 | -18,234 | -17,294 | -11,283 |
| Gain (Loss) on Sale of Investments | 1,319 | 1,142 | 358.85 | 35.43 | 168.77 |
| Gain (Loss) on Sale of Assets | -462.15 | -273.42 | - | -135.12 | - |
| Pretax Income | -12,559 | -14,056 | -17,875 | -17,393 | -11,114 |
| Net Income | -12,559 | -14,056 | -17,875 | -17,393 | -11,114 |
| Net Income to Common | -12,559 | -14,056 | -17,875 | -17,393 | -11,114 |
| Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 17 |
| Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 17 |
| Shares Change (YoY) | 1.14% | 0.84% | 0.43% | 10.20% | - |
| EPS (Basic) | -650.10 | -730.84 | -937.29 | -915.91 | -645.96 |
| EPS (Diluted) | -650.72 | -731.00 | -937.29 | -916.00 | -758.98 |
| Free Cash Flow | -9,081 | -11,008 | -16,244 | -24,743 | -19,477 |
| Free Cash Flow Per Share | -470.10 | -572.37 | -851.73 | -1302.97 | -1130.20 |
| Gross Margin | 1.54% | -0.78% | - | - | - |
| Operating Margin | -4861.71% | -5495.85% | - | - | - |
| Profit Margin | -4502.18% | -5038.78% | - | - | - |
| Free Cash Flow Margin | -3255.62% | -3946.19% | - | - | - |
| EBITDA | -10,234 | -11,700 | -15,987 | -15,296 | -11,417 |
| D&A For EBITDA | 3,328 | 3,631 | 4,098 | 2,918 | 1,718 |
| EBIT | -13,562 | -15,330 | -20,084 | -18,214 | -13,136 |
| Advertising Expenses | - | - | 2.54 | 17 | 13 |
Source: S&P Capital IQ. Standard template. Financial Sources.